Nomura Micro Science Co., Ltd.

TSE:6254.T

2400 (JPY) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 73,021.48649,595.83131,901.27730,361.43121,049.21525,131.8521,603.36716,455.08217,767.81912,111.12314,985.28213,288.48316,533.38822,016.5211,418.55321,389.37924,960.054
Cost of Revenue 57,614.35139,223.51224,244.71623,234.64216,029.94620,794.93517,263.27212,742.89414,420.8139,669.33512,751.20110,969.44913,324.80818,052.579,337.70417,891.07620,601.085
Gross Profit 15,407.13510,372.3197,656.5617,126.7895,019.2694,336.9154,340.0953,712.1883,347.0062,441.7882,234.0812,319.0343,208.583,963.952,080.8493,498.3034,358.969
Gross Profit Ratio 0.2110.2090.240.2350.2380.1730.2010.2260.1880.2020.1490.1750.1940.180.1820.1640.175
Reseach & Development Expenses 341256207188254259199.128297.936360.32445039429800000
General & Administrative Expenses 42840541142539835734229433027026824500000
Selling & Marketing Expenses 3,9903,1612,6052,8912,5212,5072,558.1492,350.7342,340.1772,2712,2592,13600000
SG&A 4,417.4843,5663,0163,3162,9192,8642,900.1492,644.7342,670.1772,5412,5272,38100000
Other Expenses 0.87664.13239.05630.73227.27925.4441.55741.58750.99232.94255.42721.782-25.8338.73612.20610.319-23.01
Operating Expenses 4,759.363,822.2593,223.4243,153.8293,173.023,123.0533,099.2772,942.673,030.52,991.1742,9212,711.7412,609.2822,746.8862,464.8062,709.0242,972.598
Operating Income 10,647.7756,550.0594,433.1363,972.9591,846.2481,213.8611,240.818769.517316.505-549.386-686.919-392.707599.2981,217.063-383.957789.2791,386.371
Operating Income Ratio 0.1460.1320.1390.1310.0880.0480.0570.0470.018-0.045-0.046-0.030.0360.055-0.0340.0370.056
Total Other Income Expenses Net 179.834900.222145.282-363.572-56.989156.999-110.588-27.411-135.57832.769305.664433.074-228.118210.178-309.651-378.423-639.775
Income Before Tax 10,827.6097,450.2814,578.4183,609.3871,789.2591,370.861,130.23742.106180.927-516.617-381.25540.367371.181,134.605-693.608410.856746.596
Income Before Tax Ratio 0.1480.150.1440.1190.0850.0550.0520.0450.01-0.043-0.0250.0030.0220.052-0.0610.0190.03
Income Tax Expense 2,849.5851,643.5941,286.912991.005515.877340.765126.00651.33930.18467.52623.609146.59216.409509.875-204.83263.248280.64
Net Income 7,978.0235,806.6873,291.5062,618.3811,273.3811,030.0951,004.327691.1151.198-983.684-404.825-106.223154.297620.739-488.21486.23300.884
Net Income Ratio 0.1090.1170.1030.0860.060.0410.0460.0420.009-0.081-0.027-0.0080.0090.028-0.0430.0040.012
EPS 213.47156.989.471.234.77113.05111.0977.7217.01-110.7-45.3-11.381645.26-49.478.5932.96
EPS Diluted 209.7155.5488.5770.7634.73112.74110.3977.7217.01-110.7-45.3-11.381645.26-49.478.5932.96
EBITDA 11,724.0687,698.4064,781.9633,766.8922,010.6471,625.8871,368.9361,001.073525.753-56.2610.038377.652729.8591,505.599-288.525784.6921,100.933
EBITDA Ratio 0.1610.1550.150.1240.0960.0650.0630.0610.03-0.0050.0010.0280.0440.068-0.0250.0370.044